Clinical Trials Browser

Phase 1/2 × LY-2157299 × CNS × Clear all

NCT01220271 2017-02-16

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

Phase 1/2 Completed

Glioblastoma, Glioma